Antitumor effects of OSU‐2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepatology

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.24293PMID 21391227PMCID PMC3103615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.

  2010cited by this paper
• Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers.

  2010cited by this paper
• FTY720 Shows Promising In vitro and In vivo Preclinical Activity by Downmodulating Cyclin D1 and Phospho-Akt in Mantle Cell Lymphoma

  2010cited by this paper
• PTEN‐ and p53‐mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice

  2010cited by this paper
• Multiple sclerosis: Closing in on an oral treatment

  2010cited by this paper
• Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors.

  2009cited by this paper
• Targeting of the Akt-Nuclear Factor-κB Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma

  2009cited by this paper
• Sorafenib in advanced hepatocellular carcinoma.

  2008cited by this paper
• Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples.

  2008cited by this paper
• Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors.

  2008cited by this paper
• FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.

  2008cited by this paper
• Sorafenib in advanced hepatocellular carcinoma.

  2008cited by this paper
• “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets

  2008cited by this paper
• Protein kinase Cdelta and apoptosis.

  2007cited by this paper
• Protein Kinase C and Apoptosis

  2007cited by this paper
• The proapoptotic tumor suppressor protein kinase C-delta is lost in human squamous cell carcinomas.

  2006cited by this paper
• Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived Phosphoinositide-Dependent Kinase-1 Inhibitor

  2006cited by this paper
• The proapoptotic tumor suppressor protein kinase C-δ is lost in human squamous cell carcinomas

  2006cited by this paper
• Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma

  2005cited by this paper
• Pathogenesis of hepatocellular carcinoma.

  2005cited by this paper
• Opportunities for targeted therapies in hepatocellular carcinoma.

  2005cited by this paper
• FTY720-Induced Lymphocyte Homing Modulates Post-Transplant Preservation/Reperfusion Injury

  2004cited by this paper
• Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas.

  2004cited by this paper
• FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.

  2004cited by this paper
• Reactive Oxygen Species Produced by NAD(P)H Oxidase Inhibit Apoptosis in Pancreatic Cancer Cells*

  2004cited by this paper
• NOX enzymes and the biology of reactive oxygen

  2004cited by this paper
• The enigmatic protein kinase Cδ: complex roles in cell proliferation and survival

  2004cited by this paper
• Immunohistochemical Expression of π Class Glutathione S-Transferase and α-Fetoprotein in Hepatocellular Carcinoma and Chronic Liver Disease

  2003cited by this paper
• Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.

  2003cited by this paper
• The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors*

  2002cited by this paper
• Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols.

  2000cited by this paper
• GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.

  2000cited by this paper
• The Balance between Sphingosine and Sphingosine-1-Phosphate Is Decisive for Mast Cell Activation after Fc∈ Receptor I Triggering

  1999cited by this paper
• The Balance between Sphingosine and Sphingosine-1-phosphate Is Decisive for Mast Cell Activation after Fc (cid:101) Receptor I Triggering

  1999cited by this paper

• Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics.

  2025cites this paper
• Protein Kinase C Family: Structures, Biological Functions, Diseases, and Pharmaceutical Interventions

  2025cites this paper
• Integrative roles of sphingosine kinase in liver pathophysiology

  2023cites this paper
• Genetic Analysis of Platelet-Related Genes in Hepatocellular Carcinoma Reveals a Novel Prognostic Signature and Determines PRKCD as the Potential Molecular Bridge

  2022cites this paper
• Multiple subcellular localizations and functions of protein kinase Cδ in liver cancer

  2022cites this paper
• Sphingosine‐1‐phosphate in mitochondrial function and metabolic diseases

  2022cites this paper
• Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy

  2021cites this paper
• PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia

  2021cites this paper
• Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies

  2020cites this paper
• Fingolimod inhibits proliferation and epithelial–mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signalling

  2020cites this paper
• Fingolimodinhibits proliferation and epithelial-mesenchymal 1 transition in sacral chordoma by inactivating IL-6 / STAT 3 2 signalling 3

  2020cites this paper
• Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing Aldob/Akt/PP2A protein complex

  2020cites this paper
• Pharmacokinetics and Tolerability of the Novel Non-immunosuppressive Fingolimod Derivative, OSU-2S, in Dogs and Comparisons with Data in Mice and Rats

  2020cites this paper
• Chemical genetic analysis of FTY720‐ and Ca2+‐sensitive mutants reveals a functional connection between FTY720 and membrane trafficking

  2020cites this paper
• Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex

  2020cites this paper
• Ultrasound-mediated delivery of RGD-conjugated nanobubbles loaded with fingolimod and superparamagnetic iron oxide nanoparticles: targeting hepatocellular carcinoma and enhancing magnetic resonance imaging

  2020cites this paper
• Antineoplastic Agents Targeting Sphingolipid Pathways

  2020cites this paper
• The Loss of p21-Activated Kinase (Pak1) Promotes Atrial Arrhythmic Activity: The Role of Pak1 in Atrial Arrhythmia

  2020cites this paper
• Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration

  2019cites this paper
• The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers.

  2019cites this paper
• Mission Possible: Advances in MYC Therapeutic Targeting in Cancer

  2019cites this paper
• A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.

  2019cites this paper
• RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth

  2019cites this paper
• Targeting PP2A in cancer: Combination therapies.

  2019cites this paper
• Receptor-interacting Ser/Thr kinase 1 (RIPK1) and myosin IIA–dependent ceramidosomes form membrane pores that mediate blebbing and necroptosis

  2018cites this paper
• Loss of p21-activated kinase 1 (Pak1) promotes atrial arrhythmic activity.

  2018cites this paper
• Bis-(5-substituted-2-thiono-1,3,5-thiadiazinan-3-yl) butane as a scaffold of anti-proliferative activity, blended by a multicomponent process

  2018cites this paper
• More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis

  2018cites this paper
• Therapeutic targeting of PP2A.

  2018cites this paper
• Enhancing the Anticancer Activity of Antrodia cinnamomea in Hepatocellular Carcinoma Cells via Cocultivation With Ginger: The Impact on Cancer Cell Survival Pathways

  2018cites this paper
• Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma

  2018cites this paper
• Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphoma.

  2017cites this paper
• Obestatin improves hepatic injury induced by ischemia/reperfusion in rats: Role of nitric oxide.

  2017cites this paper
• The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives.

  2017cites this paper
• Sphingosine 1-phosphate regulates proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells via syndecan-1.

  2017cites this paper
• Design, synthesis and biological evaluation of new pyrrolidine carboxamide analogues as potential chemotherapeutic agents for hepatocellular carcinoma.

  2017cites this paper
• A genome-wide screen for FTY720-sensitive mutants reveals genes required for ROS homeostasis

  2017cites this paper
• FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model

  2017cites this paper
• Measuring And Managing Phenotypic Heterogeneity And Plasticity In Breast Cancer To Improve Therapeutic Control

  2017cites this paper
• A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia

  2016cites this paper
• Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015)

  2016cites this paper
• Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options

  2016cites this paper
• OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53

  2016cites this paper
• Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors

  2016cites this paper
• Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review

  2016cites this paper
• Serum sphingolipidomic analyses reveal an upregulation of C16- ceramide and sphingosine-1-phosphate in hepatocellular carcinoma

  2016cites this paper
• Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?

  2016cites this paper
• The emerging role of FTY720 (Fingolimod) in cancer treatment

  2016cites this paper
• Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation

  2016cites this paper
• Preclinical and Clinical Perspective on Fungal Metabolites and Their Analogs as Anticancer Agents – From Bench to Bedside

  2016cites this paper
• Involvement of vacuolar H+‐ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720

  2015cites this paper
• Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A.

  2015cites this paper
• The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod

  2015cites this paper
• ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo.

  2015cites this paper
• Toward a Cancer Drug of Fungal Origin

  2015cites this paper
• Rapid externalization of 27‐kDa heat shock protein (HSP27) and atypical cell death in neutrophils treated with the sphingolipid analog drug FTY720

  2015cites this paper
• 6-Shogaol induces cell cycle arrest and apoptosis in human hepatoma cells through pleiotropic mechanisms.

  2015cites this paper
• Nebivolol and chrysin protect the liver against ischemia/reperfusion-induced injury in rats

  2015cites this paper
• A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted delivery.

  2014cites this paper
• Quantification of OSU-2S, a novel derivative of FTY720, in mouse plasma by liquid chromatography-tandem mass spectrometry.

  2014cites this paper
• Decorosides A and B, Cytotoxic Flavonoid Glycosides from the Leaves of Rhododendron decorum

  2014cites this paper
• OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro

  2014cites this paper
• Design, synthesis and pharmacological evaluation of novel pyrrolizine derivatives as potential anticancer agents.

  2014cites this paper
• HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics

  2014cites this paper
• Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B cell cytotoxicity in chronic lymphocytic leukemia

  2014cites this paper
• New perspectives on the role of sphingosine 1-phosphate in cancer.

  2013cites this paper
• Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.

  2013cites this paper
• FTY720 for cancer therapy (Review).

  2013cites this paper
• Lysophosphatidic Acid Aberrancies and Hepatocellular Carcinoma: Studies in the MDR2 Gene Knockout Mouse

  2013influential citation
• Protein phosphatase 2A: a target for anticancer therapy.

  2013cites this paper
• Design, synthesis and biological evaluation of novel triaryl (Z)-olefins as tamoxifen analogues.

  2013cites this paper
• Synthesis, Anti‐Breast Cancer Activity, and Molecular Modeling of Some Benzothiazole and Benzoxazole Derivatives

  2013cites this paper
• PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.

  2013influential citation
• Novel targeted therapies for mantle cell lymphoma

  2012cites this paper
• Monoclonal Antibody and Liposomal Nanoparticle-based Targeting Therapies for Chronic Lymphocytic Leukemia

  2012cites this paper
• Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma.

  2012cites this paper
• Release of overexpressed CypB activates ERK signaling through CD147 binding for hepatoma cell resistance to oxidative stress

  2012cites this paper
• FTY 720 increases CD 74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death

  2011cites this paper
• FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.

  2011cites this paper
• NPC Natural Product Communications

  2011cites this paper